Clinical trial
Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause: a Prospective Monocentric Study (CAP-TTR)
NCT05950867 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause: a Prospective Monocentric Study (CAP-TTR)
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 28, 2023
- Completion date
- June 1, 2026
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyloidosis, polyneuropathy